Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 904876, 8 pages
http://dx.doi.org/10.1155/2015/904876
Research Article

25-OH Vitamin D and Interleukin-8: Emerging Biomarkers in Cutaneous Melanoma Development and Progression

1Nephrology Hospital “Dr. Carol Davila”, 4 Calea Grivitei, 010731 Bucharest, Romania
2SKINMED Clinic, 8 Splaiul Unirii, 040102 Bucharest, Romania
3Immunology Department, Victor Babes National Institute of Pathology, 99-101 Splaiul Independentei, 050096 Bucharest, Romania
4Faculty of Biology, University of Bucharest, 91-95 Splaiul Independenţei, 76201 Bucharest, Romania
5Department in Dermatology, Infectious and Tropical Diseases “Dr. Victor Babeş” Clinical Hospital-Research, 281 Soseaua Mihai Bravu, 030303 Bucharest, Romania

Received 10 April 2015; Revised 5 June 2015; Accepted 10 June 2015

Academic Editor: Madhav Bhatia

Copyright © 2015 Corina-Daniela Ene et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Vandewalle, A. Adenis, L. Hornez, F. Revillion, and J. Lefebvre, “1,25-dihydroxyvitamin D3 receptors in normal and malignant human colorectal tissues,” Cancer Letters, vol. 86, no. 1, pp. 67–73, 1994. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Song, R. Nishihara, M. Wang et al., “Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status,” Gut, 2015. View at Publisher · View at Google Scholar
  3. K. Sharma, R. W. Goehe, X. Di et al., “A novel cytostatic form of autophagy in sensitization of non-small cell lung cancer cells to radiation by vitamin D and the vitamin D analog, EB 1089,” Autophagy, vol. 10, no. 12, pp. 2346–2361, 2015. View at Publisher · View at Google Scholar
  4. S. Imtiaz and N. Siddiqui, “Vitamin-D status at breast cancer diagnosis: correlation with social and environmental factors and dietary intake,” Journal of Ayub Medical College Abbottabad, vol. 26, no. 2, pp. 186–190, 2014. View at Google Scholar
  5. A. Juzeniene, A. C. Porojnicu, Z. Baturaite et al., “Vitamin D levels and dietary intake among patients with benign soft tissue tumors and sarcomas,” Anticancer Research, vol. 35, no. 2, pp. 1171–1180, 2015. View at Google Scholar
  6. K. M. Wesa, N. H. Segal, A. M. Cronin et al., “Serum 25-hydroxy vitamin D and survival in advanced colorectal cancer: a retrospective analysis,” Nutrition and Cancer, vol. 67, no. 3, pp. 424–430, 2015. View at Publisher · View at Google Scholar
  7. B. Bade, A. Zdebik, S. Wagenpfeil et al., “Low serum 25-hydroxyvitamin D concentrations are associated with increased risk for melanoma and unfavourable prognosis,” PLoS ONE, vol. 9, no. 12, Article ID e112863, 2014. View at Publisher · View at Google Scholar
  8. H. B. Lowman, W. J. Fairbrother, P. H. Slagle et al., “Monomeric variants of IL-8: effects of sidechain substitutions and solution conditions upon dimer formation,” Protein Science, vol. 6, no. 3, pp. 598–608, 1997. View at Google Scholar · View at Scopus
  9. S. Pastore, D. Lulli, A. I. Potapovich et al., “Differential modulation of stress-inflammation responses by plant polyphenols in cultured normal human keratinocytes and immortalized HaCaT cells,” Journal of Dermatological Science, vol. 63, no. 2, pp. 104–114, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. C. R. Mangahas, G. V. dela Cruz, G. Friedman-Jiménez, and S. Jamal, “Endothelin-1 induces CXCL1 and CXCL8 secretion in human melanoma cells,” Journal of Investigative Dermatology, vol. 125, no. 2, pp. 307–311, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Kolář, P. Szabo, B. Dvořánková et al., “Upregulation of IL-6, IL-8 and CXCL-1 production in dermal fibroblasts by normal/malignant epithelial cells in vitro: immunohistochemical and transcriptomic analyses,” Biology of the Cell, vol. 104, no. 12, pp. 738–751, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. D. J. J. Waugh and C. Wilson, “The interleukin-8 pathway in cancer,” Clinical Cancer Research, vol. 14, no. 21, pp. 6735–6741, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Harant, P. J. Andrew, G. S. Reddy, E. Foglar, and I. J. D. Lindley, “1α,25-dihydroxyvitamin D3 and a variety of its natural metabolites transcriptionally repress nuclear-factor-κB-mediated interleukin-8 gene expression,” European Journal of Biochemistry, vol. 250, no. 1, pp. 63–71, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. A. T. Slominski, T.-K. Kim, Z. Janjetovic et al., “20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells,” The American Journal of Physiology—Cell Physiology, vol. 300, no. 3, pp. C526–C541, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Essa, S. Reichrath, U. Mahlknecht, M. Montenarh, T. Vogt, and J. Reichrath, “Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines,” Anticancer Research, vol. 32, no. 1, pp. 383–389, 2012. View at Google Scholar · View at Scopus
  16. T. Gambichler, M. Bindsteiner, S. Höxtermann, and A. Kreuter, “Serum 25-hydroxyvitamin D serum levels in a large German cohort of patients with melanoma,” British Journal of Dermatology, vol. 168, no. 3, pp. 625–628, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Kelderman, B. Heemskerk, H. van Tinteren et al., “Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma,” Cancer Immunology, Immunotherapy, vol. 63, no. 5, pp. 449–458, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. S. R. Palmer, L. A. Erickson, I. Ichetovkin, D. J. Knauer, and S. N. Markovic, “Circulating serologic and molecular biomarkers in malignant melanoma,” Mayo Clinic Proceedings, vol. 86, no. 10, pp. 981–990, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. C. D. Nicolae and I. Nicolae, “Antibodies against GM1 Gangliosides associated with metastatic melanoma,” Acta Dermatovenerologica Croatica, vol. 21, no. 2, pp. 86–92, 2013. View at Google Scholar · View at Scopus
  20. C. D. Ene and I. Nicolae, “Gangliosides and antigangliosides in malignant melanoma,” in Melanoma—Current Clinical Management and Future Therapeutics, M. Murph, Ed., chapter 14, InTech, Rijeka, Croatia, 2015. View at Publisher · View at Google Scholar
  21. H. Zhai and H. I. Maibach, Eds., Dermatotoxicology, CRC Press, 6th edition, 2004.
  22. “Melanoma of the skin,” in AJCC Cancer Staging Manual, S. B. Edge, D. R. Byrd, C. C. Compton et al., Eds., pp. 325–344, Springer, New York, NY, USA, 7th edition, 2010.
  23. M. Neagu, C. Constantin, and S. Zurac, “Immune parameters in the prognosis and therapy monitoring of cutaneous melanoma patients: experience, role, and limitations,” BioMed Research International, vol. 2013, Article ID 107940, 13 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Ferlay, E. Steliarova-Foucher, J. Lortet-Tieulent et al., “Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012,” European Journal of Cancer, vol. 49, no. 6, pp. 1374–1403, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. P. W. Thavasu, S. Longhurst, S. P. Joel, M. L. Slevin, and F. R. Balkwill, “Measuring cytokine levels in blood. Importance of anticoagulants, processing, and storage conditions,” Journal of Immunological Methods, vol. 153, no. 1-2, pp. 115–124, 1992. View at Publisher · View at Google Scholar · View at Scopus
  26. http://www.euroimmun.ch/uploads/media/EQ_6411_I_UK_A02.pdf.
  27. http://www.enzolifesciences.com/ADI-900-156/il-8-human-elisa-kit/.
  28. H. Zhang, T. Fu, S. McGettigan et al., “IL-8 and cathepsin B as melanoma serum biomarkers,” International Journal of Molecular Sciences, vol. 12, no. 3, pp. 1505–1518, 2011. View at Publisher · View at Google Scholar
  29. P. Vereecken, F. Cornelis, N. Van Baren, V. Vandersleyen, and J.-F. Baurain, “A synopsis of serum biomarkers in cutaneous melanoma patients,” Dermatology Research and Practice, vol. 2012, Article ID 260643, 7 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Vinceti, C. Malagoli, C. Fiorentini et al., “Inverse association between dietary vitamin D and risk of cutaneous melanoma in a Northern Italy population,” Nutrition and Cancer, vol. 63, no. 4, pp. 506–513, 2011. View at Google Scholar · View at Scopus
  31. U. Reinhold, B. Schmitz, C. Kurbacher, W. Nagel, M. Schmidt, and W. J. Malaisse, “Circulating 25-hydroxyvitamin D concentration in German cancer patients,” Oncology Reports, vol. 20, no. 6, pp. 1539–1543, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. O. Kodet, L. Lacina, E. Krejčí et al., “Melanoma cells influence the differentiation pattern of human epidermal keratinocytes,” Molecular Cancer, vol. 14, no. 1, article 1, 2015. View at Google Scholar
  33. W. Uen, C. Hsieh, T. Tseng, S. S. Jiang, J. Tseng, and S. Lee, “Anchorage independency promoted tumor malignancy of melanoma cells under reattachment through elevated interleukin-8 and CXC chemokine receptor 1 expression,” Melanoma Research, vol. 25, no. 1, pp. 35–46, 2015. View at Publisher · View at Google Scholar
  34. M. F. Sanmamed, O. Carranza-Rua, C. Alfaro et al., “Serum interleukin-8 reflects tumor burden and treatment response across malignancies of multiple tissue origins,” Clinical Cancer Research, vol. 20, no. 22, pp. 5697–5707, 2014. View at Publisher · View at Google Scholar
  35. M. A. Khan, S. Andrews, R. Ismail-Khan et al., “Overall and progression-free survival in metastatic melanoma: analysis of a single-institution database,” Cancer Control, vol. 13, no. 3, pp. 211–217, 2006. View at Google Scholar · View at Scopus
  36. P. Vereecken, K. Z. Boudjeltia, C. Debray et al., “High serum galectin-3 in advanced melanoma: preliminary results,” Clinical and Experimental Dermatology, vol. 31, no. 1, pp. 105–109, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Neagu, C. Constantin, G. Manda, and I. Margaritescu, “Biomarkers of metastatic melanoma,” Biomarkers in Medicine, vol. 3, no. 1, pp. 71–89, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Wang, D. Liu, W. Ning, and A. Xu, “Cytosolic dsDNA triggers apoptosis and pro-inflammatory cytokine production in normal human melanocytes,” Experimental Dermatology, vol. 24, no. 4, pp. 298–300, 2015. View at Publisher · View at Google Scholar
  39. M. Neagu, C. Constantin, G. R. Dumitrascu et al., “Inflammation markers in cutaneous melanoma—edgy biomarkers for prognosis,” Discoveries, vol. 3, no. 1, Article ID e38114, 2015. View at Publisher · View at Google Scholar
  40. J. Chen, J. Wang, T. K. Kim et al., “Novel vitamin D analogs as potential therapeutics: metabolism, toxicity profiling, and antiproliferative activity,” Anticancer Research, vol. 34, no. 5, pp. 2153–2163, 2014. View at Google Scholar
  41. A. Diaconeasa, D. Boda, M. Neagu et al., “The role of confocal microscopy in the dermato-oncology practice,” Journal of Medicine and Life, vol. 4, no. 1, pp. 63–74, 2011. View at Google Scholar · View at Scopus